Cancer-Associated Thrombosis: Epidemiology, Pathophysiological Mechanisms, Treatment, and Risk Assessment [0.03%]
癌症相关血栓 : 流行病学、病理生理机制、治疗和危险因素评估
Dragica Pavlovic,Danijela Niciforovic,Marina Markovic et al.
Dragica Pavlovic et al.
Cancer patients represent a growing population with drastically difficult care and a lowered quality of life, especially due to the heightened risk of vast complications. Thus, it is well established so far that one of the most prominent co...
Cong-Gai Huang,Qing Liu,Shu-Tao Zheng et al.
Cong-Gai Huang et al.
Background: Evaluation of biological changes at the molecular level has important clinical implications for improving the survival rate of esophageal squamous cell carcinoma (ESCC). Therefore, we plan to analyze and eluci...
Influence of Smoking Habits on the Efficacy of EGFR-TKI Therapy in Patients with Advanced NSCLC: A Systematic Review and Meta-Analysis [0.03%]
吸烟习惯对晚期NSCLC患者EGFR-TKI疗效的影响：系统评价和Meta分析
Zexun Mo,Meifeng Ye,Hua He et al.
Zexun Mo et al.
Background: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are considered as the first-line treatment for advanced EGFR mutation-positive non-small cell lung cancer (NSCLC). We aimed to analyze th...
A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma [0.03%]
碘131利妥昔单抗治疗复发或难治的边缘区淋巴瘤患者的II期研究
Yoon Jung Jang,Sang Moo Lim,Inki Lee et al.
Yoon Jung Jang et al.
Background: Radioimmunotherapy (RIT) is a rare treatment option for relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL). We investigated the safety and efficacy of 131I-rituximab in patients with relapsed or refrac...
BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia [0.03%]
BCL11B突变与T细胞急性淋巴细胞白血病患者的更高CD8+T细胞百分比和更好的临床结果相关
Cunte Chen,Yuping Zhang,Xiangbo Zeng et al.
Cunte Chen et al.
Circadian Clock Dysregulation and Prostate Cancer: A Molecular and Clinical Overview [0.03%]
昼夜钟紊乱与前列腺癌：分子和临床概述
Dalia Kaakour,Bridget Fortin,Selma Masri et al.
Dalia Kaakour et al.
Circadian clock dysregulation has been implicated in various types of cancer and represents an area of growing research. However, the role of the circadian clock in prostate cancer has been relatively unexplored. This literature review will...
Clinical Pathological Characteristics and Prognosis of Multigene Co-Mutations in Elderly Patients With Non-Small Cell Lung Cancer: A Retrospective Analysis [0.03%]
老年非小细胞肺癌多基因共突变的临床病理特征及预后：回顾性分析
Wanjing Li,Fangqun Chang,Hao Zhang et al.
Wanjing Li et al.
Background: With the development and wide application of next-generation sequencing (NGS), multiple-gene mutations related to lung cancer are detected using this technology. Notably, even multigene concomitant mutations (...
A Systematic Review of Clinical Practice Guidelines for Managing Pulmonary Toxicities Caused by Immune Checkpoint Inhibitors: Quality of Treatment Recommendations and Differences in Management Strategies Between Guidelines [0.03%]
免疫检查点抑制剂所致肺毒症管理的临床实践指南系统 review：治疗推荐的质量及指南间管理策略的差异
Kofi N Donkor,Hyeree Jang,Reena Sail
Kofi N Donkor
Background: Pulmonary toxicities caused by immune checkpoint inhibitors are a prominent concern for clinicians. Clinical Practice Guidelines (CPGs) are critical for managing these toxicities. ...
Joanna Chorbińska,Wojciech Krajewski,Łukasz Nowak et al.
Joanna Chorbińska et al.
Background: Microbiome dysbiosis plays a role in the pathogenesis of many urological diseases, including bladder cancer (BC). The aim of the study was to compare the urinary and gut microbiota of patients with BC with a h...
Clinicopathologic Features and Prognosis of Female Early Breast Cancer With HER2 Low Expression: A Propensity Score Matched Analysis [0.03%]
HER2低表达女性早期乳腺癌的临床病理特征及预后：倾向得分析分
Lanyi Dai,Qiyuan Huang,Rong Guo et al.
Lanyi Dai et al.
Background: Metastatic breast cancer (MBC) patients with low expression of human epidermal growth factor 2 (HER2) have been proven to benefit from HER2 targeted therapy. We aimed to determine how HER2-low status affected ...